ImmuneHuman RCT
ARA-290 (cibinetide): what the small nerve-repair trials found
Three small phase 2 trials suggest it can regrow damaged small nerve fibres; the pain results are weaker, and there has never been a phase 3 trial.
ARA-290
An 11-amino-acid peptide modelled on part of erythropoietin; three small phase 2 trials showed nerve-fibre regrowth, with weaker evidence on pain.
- Also known as
- Cibinetide, ARA 290, pyroglutamate helix B surface peptide, pHBSP
- Area
- Immune
- Status
- Investigational; not approved as a medicine anywhere